Back to 
DODGE & COX
DODGE & COX
CORT
Showing 0 of 2 quarters
Position history for DODGE & COX's holdings in Corcept Therapeutics Incorporated.
No. Dodge & Cox exited its CORT (Corcept Therapeutics) position in Q2 2023. Its Q1 2023 13F listed 21,528 shares worth $466,296. Dodge & Cox first reported CORT in Q1 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.